Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $63.1B
1-Year Est. Return 32.57%
This Quarter Est. Return
1 Year Est. Return
+32.57%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$63.1B
AUM Growth
+$3.79B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
999
New
Increased
Reduced
Closed

Top Buys

1
+$510M
2
+$210M
3
+$177M
4
JNJ icon
Johnson & Johnson
JNJ
+$172M
5
CYBR icon
CyberArk
CYBR
+$139M

Top Sells

1
+$1.35B
2
+$231M
3
+$191M
4
ARGX icon
argenx
ARGX
+$164M
5
XOM icon
Exxon Mobil
XOM
+$163M

Sector Composition

1 Technology 30.32%
2 Healthcare 13.97%
3 Financials 11.87%
4 Consumer Discretionary 9.55%
5 Communication Services 9.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PRA icon
926
ProAssurance
PRA
$1.23B
– –
-492,566
PRCT icon
927
Procept Biorobotics
PRCT
$1.85B
– –
-100,000
RF icon
928
Regions Financial
RF
$23B
– –
-198,300
RH icon
929
RH
RH
$3.04B
– –
-50,000
RRX icon
930
Regal Rexnord
RRX
$9.16B
– –
-37,529
SANA icon
931
Sana Biotechnology
SANA
$1.19B
– –
-702,000
SGML icon
932
Sigma Lithium
SGML
$1.12B
– –
-900,000
SILJ icon
933
Amplify Junior Silver Miners ETF
SILJ
$3.13B
– –
-250,000
SKWD icon
934
Skyward Specialty Insurance
SKWD
$1.83B
– –
-20,000
SKX
935
DELISTED
Skechers
SKX
– –
-848,872
SPRY icon
936
ARS Pharmaceuticals
SPRY
$944M
– –
-1,728,000
SSTK icon
937
Shutterstock
SSTK
$696M
– –
-100,000
STR
938
DELISTED
Sitio Royalties
STR
– –
-6,783,254
SUI icon
939
Sun Communities
SUI
$15.7B
– –
-80,000
SYRE icon
940
Spyre Therapeutics
SYRE
$2.5B
– –
-610,200
TAK icon
941
Takeda Pharmaceutical
TAK
$45.2B
– –
-2,533,725
TARA icon
942
Protara Therapeutics
TARA
$262M
– –
-400,000
TARS icon
943
Tarsus Pharmaceuticals
TARS
$3.48B
– –
-543,000
TEVA icon
944
Teva Pharmaceuticals
TEVA
$31.9B
– –
-534,000
TKR icon
945
Timken Company
TKR
$5.75B
– –
-177,828
TNDM icon
946
Tandem Diabetes Care
TNDM
$1.35B
– –
-250,000
TRI icon
947
Thomson Reuters
TRI
$59.7B
– –
-132,000
TRML
948
DELISTED
Tourmaline Bio
TRML
– –
-135,637
TRU icon
949
TransUnion
TRU
$16.2B
– –
-100,000
URGN icon
950
UroGen Pharma
URGN
$1.14B
– –
-830,000
36 37
38
39 40